Mendota Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43
Closed -$4.37K 49
2025
Q4
$4.37K Hold
43
﹤0.01% 94
2025
Q3
$2.35K Hold
43
﹤0.01% 110
2025
Q2
$2.29K Hold
43
﹤0.01% 93
2025
Q1
$1.86K Hold
43
﹤0.01% 107
2024
Q4
$2.42K Sell
43
-626
-94% -$39K ﹤0.01% 291
2024
Q3
$45.6K Sell
669
-284
-30% -$16K 0.02% 183
2024
Q2
$40.3K Hold
953
0.02% 185
2024
Q1
$65.8K Hold
953
0.04% 163
2023
Q4
$70.5K Buy
953
+825
+645% +$54.1K 0.06% 174
2023
Q3
$8.73K Buy
128
+10
+8% +$848 0.01% 199
2023
Q2
$11.1K Hold
118
0.01% 195
2023
Q1
$8.25K Hold
118
0.01% 237
2022
Q4
$5.84K Buy
+118
New +$4.82K 0.01% 228

Other funds holding EXAS

Mendota Financial Group's EXAS Position: Q1 2026 in Review

Mendota Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 43 shares — an estimated $4.37K sold.

Mendota Financial Group first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $70.5K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mendota Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mendota Financial Group sold 43 Exact Sciences shares in Q1 2026, an estimated $4.37K.
  • Mendota Financial Group first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Mendota Financial Group's Exact Sciences position peaked at $70.5K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mendota Financial Group's 13F filing for Q1 2026, filed 16 Apr 2026.